Top Markets
#1 Palladium Network Palladium Network +27.91%
#2 Ankr Network Ankr Network +23.31%
#3 Status Status +12.66%
#4 BankrCoin BankrCoin +11.35%
#5 ICON ICON +11.33%
#6 Siren Siren +8.72%
#7 Wiki Cat Wiki Cat +8.34%
#8 WAX WAX +7.72%
#9 Wrapped Aave Ethereum WETH Wrapped Aave Ethereum WETH +7.22%
#10 would would +6.93%
Coin of the day
Palladium Network Palladium Network
Settings
Language
ENGLISH
Currency
USD
Theme
ProQR Therapeutics N.V. ProQR Therapeutics N.V.

ProQR Therapeutics N.V.

PRQR
Rank in Stocks #17698
ProQR Therapeutics N.V. operates as a biopharmaceutical enterprise dedicated to... ProQR Therapeutics N.V. operates as a biopharmaceutical enterprise dedicated to discovering and developing RNA-based therapies designed to address genetic disorders. The company's pipeline includes two primary drug candidates in advanced clinical stages: Sepofarsen is currently in a Phase II/III clinical trial, known as the ILLUMINATE trial, targeting Leber Congenital Amaurosis 10 (LCA10). Ultevursen is also undergoing Phase II/III evaluation for the treatment of USH2A-mediated retinitis pigmentosa and Usher syndrome. Beyond its clinical programs, ProQR is actively developing its proprietary Axiomer RNA base-editing platform technology. Strategic collaborations are central to ProQR's strategy, evidenced by its licensing agreements with institutions such as Radboud University Medical Center, Inserm Transfert SA, Ionis Pharmaceuticals, Inc., and Leiden University Medical Center. Furthermore, a significant license and research partnership exists with Eli Lilly and Company, focused on the discovery, advancement, and commercialization of novel medicines for genetic conditions impacting the liver and nervous system. Established in 2012, ProQR Therapeutics N.V. maintains its corporate headquarters in Leiden, the Netherlands.
Share Price
$2.19
Last synced: 2026-09-02
Market Cap
$230.27M
Change (1 day)
3.14%
Change (1 year)
-10.02%
Country
NL
Trade ProQR Therapeutics N.V. (PRQR)

Category

Healthcare
Dividend history for ProQR Therapeutics N.V. (PRQR)
ProQR Therapeutics N.V. (stock symbol: PRQR) made a total of 0 dividend payments.
The sum of all dividends (adjusted for stock splits) is : 0.00
Dividend yield (TTM) : 0
Dividend payments for ProQR Therapeutics N.V. (PRQR) from 2026 to 2026
Annual dividend payments
Year Dividend (stock split adjusted) Change
Not enough data for the provided dates.
List of all dividend payments
Year Dividend Change
Not enough data for the provided dates.
Dividend payments for similar companies or competitors
Company Number of dividend payments Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
64.00%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH